Security Snapshot

Cellebrite DI Ltd. - Ordinary shares, par value of NIS 0.00001 per share (CLBT) Institutional Ownership

CUSIP: M2197Q107

13F Institutional Holders and Ownership History from Q3 2021 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

199

Shares (Excl. Options)

123,569,111

Price

$14.60

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.01%
Share change
-1,674,762
Value change
-$15,843,654
Number of holders
199
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
249,019,608
SEC-reported price per share
$15.44
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • CLBT - Cellebrite DI Ltd. - Ordinary shares, par value of NIS 0.00001 per share is tracked under CUSIP M2197Q107.
  • 199 institutions reported positions in Q2 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 221 to 199 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $1,743,789,534 to $1,804,169,716.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 199 institutions filings for Q2 2026.

Open SEC evidence

Security key

M2197Q107

Latest holder period

Q2 2026

13F holders

199

13D/G owners

4

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
CLBT
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SUNCORPORATION 43% -2.3% $1,915,539,751 +$63,014,988 106,065,324 +3.4% SUNCORPORATION 31 Dec 2025
TWC Tech Holdings II, LLC 6.1% $294,700,753 14,661,729 Adam H. Clammer 18 Mar 2025
Voss Capital, LP 5.1% $196,088,000 12,700,000 Voss Capital, LP 13 Aug 2026
FMR LLC 4.1% -22% $199,496,862 -$13,992,153 9,925,217 -6.6% FMR LLC 31 Mar 2025

As of 30 Jun 2026, 199 institutional investors reported holding 123,569,111 shares of Cellebrite DI Ltd. - Ordinary shares, par value of NIS 0.00001 per share (CLBT). This represents 50% of the company’s total 249,019,608 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
37%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
True Wind Capital Management, L.P. 5.6% 13,861,007 0% 90% $202,370,702
Voss Capital, LP 4.6% 11,441,874 +18% 8.3% $167,051,360
Pertento Partners LLP 3.2% 8,004,867 +20% 8.4% $116,871,058
Phoenix Financial Ltd. 2.5% 6,181,269 +48% 0.62% $90,240,208
FMR LLC 2.4% 5,971,666 -30% 0% $87,186,318
BlackRock, Inc. 2.3% 5,684,040 +70% 0% $82,986,980
Nine Ten Capital Management LLC 1.7% 4,126,808 +20% 19% $60,251,000
Artisan Partners Limited Partnership 1.3% 3,266,753 +49% 0.08% $47,694,594
WELLINGTON MANAGEMENT GROUP LLP 1.2% 3,049,904 +94% 0.01% $44,528,599
Clal Insurance Enterprises Holdings Ltd 1.1% 2,773,014 -13% 0.18% $40,486,000
T. Rowe Price Investment Management, Inc. 0.96% 2,380,602 -28% 0.02% $34,757,000
MORGAN STANLEY 0.88% 2,193,732 +5.4% 0% $32,028,492
RENAISSANCE TECHNOLOGIES LLC 0.86% 2,150,239 -25% 0.04% $31,393,489
Capital World Investors 0.85% 2,112,733 +880% 0% $30,845,902
Capital International Investors 0.83% 2,060,957 -9.5% 0.01% $30,089,972
Progeny 3, Inc. 0.8% 2,000,000 +77% 1.5% $29,200,000
Portolan Capital Management, LLC 0.78% 1,932,514 -11% 1.1% $28,214,704
Weiss Asset Management LP 0.77% 1,923,351 +1.2% 0.31% $28,080,925
Bank of New York Mellon Corp 0.7% 1,744,018 +31% 0% $25,462,665
Orbis Allan Gray Ltd 0.69% 1,707,749 0.09% $24,933,136
Granahan Investment Management, LLC 0.67% 1,661,163 -4.5% 0.86% $24,252,980
RAYMOND JAMES FINANCIAL INC 0.64% 1,600,460 +15% 0.01% $23,366,701
PRINCIPAL FINANCIAL GROUP INC 0.62% 1,547,662 -28% 0.01% $22,595,865
Praesidium Investment Management Company, LLC 0.6% 1,494,438 -20% 10% $21,818,795
Apis Capital Advisors, LLC 0.59% 1,470,000 +6.5% 2.1% $21,462,000

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
20
Latest
Q2 2026
Rows shown
1-20 of 20
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 123,569,111 $1,804,169,716 -$15,843,654 $14.60 199
2026 Q1 126,612,338 $1,743,789,534 -$77,986,832 $13.78 221
2025 Q4 129,178,332 $2,327,539,201 +$10,666,072 $18.03 209
2025 Q3 129,479,868 $2,399,228,901 +$236,282,955 $18.53 196
2025 Q2 118,023,067 $1,888,023,265 +$96,376,127 $16.00 207
2025 Q1 111,091,356 $2,158,060,728 +$17,336,152 $19.43 196
2024 Q4 109,611,642 $2,414,743,153 +$172,628,937 $22.03 190
2024 Q3 92,027,552 $1,549,738,036 +$162,565,361 $16.84 162
2024 Q2 82,827,477 $989,795,174 +$84,273,008 $11.95 146
2024 Q1 75,864,626 $836,285,496 +$117,532,707 $11.08 138
2023 Q4 86,517,854 $748,725,177 +$75,873,899 $8.66 116
2023 Q3 53,304,550 $402,692,089 +$106,109,469 $7.65 93
2023 Q2 38,873,021 $279,822,194 +$12,002,094 $7.20 75
2023 Q1 37,362,412 $227,499,632 +$5,419,519 $6.09 57
2022 Q4 40,117,660 $174,910,523 -$3,630,060 $4.36 51
2022 Q3 41,084,252 $161,537,648 +$10,182,285 $3.92 43
2022 Q2 38,483,927 $196,125,190 -$3,326,950 $5.10 45
2022 Q1 38,618,479 $247,169,160 +$8,435,170 $6.40 49
2021 Q4 36,614,332 $293,619,620 +$8,905,659 $8.02 48
2021 Q3 21,734,465 $200,833,000 +$200,767,000 $9.26 25
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .